Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.
By S. Chiou, Mong-Lien Wang, Y. Chou, Chi-Jen Chen, Chun-Fu Hong, W. Hsieh, Hsin-Tzu Chang, Ying-Shan Chen, Tzu-Wei Lin, Han-Sui Hsu and 1 more. Cancer Research, 2010
602 citations recorded by the source corpus.
Subfields: Cancer Research, Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/40c71b8a5e31e906d58ee7aea604e9ac4e05b10e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Pengfei Shi
- H. Cui
- Zhen Dong
- Fei Chen
- Gaichao Zhao
- Jiayi Zhang
- Wen Peng
- Guanghui Zhang
Citations in the corpus
- Targeting cancer stem cell pathways for cancer therapy (2020, background): “[86] [87] [88] [89] [90] Compared to levels in benign tissues, Nanog messenger RNA (mRNA) is elevated in malignant tumors.”